Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)-Ethics Subcommittee (ES), 3909 [2011-1232]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 14 / Friday, January 21, 2011 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Family History
and Diamond Blackfan Anemia, DD11–
010, Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date
11 a.m.–5 p.m., April 19, 2011 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of ‘‘Family History and Diamond
Blackfan Anemia, DD11–010, initial review.’’
Contact Person for More Information:
Michael Dalmat, DrPH, Scientific Review
Officer, CDC, National Center for Chronic
Disease Prevention and Health Promotion,
Office of the Director, Extramural Research
Program Office, 4770 Buford Highway, NE.,
Mailstop K–92, Atlanta, GA 30341,
Telephone: (770) 488–6423, E-mail:
MED1@CDC.GOV.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: January 7, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–1233 Filed 1–20–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)—Ethics
Subcommittee (ES)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
VerDate Mar<15>2010
13:45 Jan 20, 2011
Jkt 223001
announces the following meeting of the
aforementioned subcommittee:
Times and Dates:
1 p.m.–5 p.m., February 17, 2011; 8:30
a.m.–12:30 p.m., February 18, 2011.
Place: CDC, Thomas R. Harkin Global
Communications Center, Distance
Learning Auditorium, 1600 Clifton
Road, NE., Atlanta, GA 30333. This
meeting is also available by
teleconference. Please dial (877)
928–1204 and enter code 4305992.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 60
people. To accommodate public
participation in the meeting, a
conference telephone line will be
available. The public is welcome to
participate during the public comment.
The public comment periods are
tentatively scheduled for 4 p.m.–4:15
p.m. on February 17, 2011 and from
12 p.m.–12:15 p.m. on February 18,
2011.
Purpose: The ES will provide counsel
to the ACD, CDC, regarding a broad
range of public health ethics questions
and issues arising from programs,
scientists and practitioners.
Matter To Be Discussed: Agenda items
will include the following: A review of
public comments submitted on the
ethical considerations document for the
allocation of ventilators during a severe
pandemic; finalizing the presentation
for the ACD on ethical issues related to
non-communicable disease prevention
and control; and a review of the
outcome of discussions with state,
tribal, local, and territorial health
officers on public health ethics
challenges, including an assessment of
available options towards the
development of practical tools to assist
health departments in their efforts to
address these challenges.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information:
For security reasons, members of the
public interested in attending the
meeting should contact Drue Barrett,
PhD, Designated Federal Officer, ACD,
CDC–ES, 1600 Clifton Road, NE., M/S
D–50, Atlanta, Georgia 30333.
Telephone (404) 639–4690. E-mail:
dbarrett@cdc.gov. The deadline for
notification of attendance is February
11, 2011.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
3909
Dated: January 14, 2011.
Lorenzo J. Falgiano,
Acting Director, Management Analysis and
Service Office, Centers for Disease Control
and Prevention.
[FR Doc. 2011–1232 Filed 1–20–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–R–148, CMS–R–
266, and CMS–216]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension without change of a
currently approved collection; Title of
Information Collection: Limitations on
Provider Related Donations and Health
Care Related Taxes; Limitation on
Payments for Disproportionate Share
Hospitals and Supporting Regulations in
42 CFR 433.68, 433.74 and 447.272;
Use: This information collection is
necessary to ensure compliance with
Sections 1903 and 1923 of the Social
Security Act for the purpose of
preventing payments of Federal
financial participation on amounts
prohibited by statute; Form Number:
CMS–R–148 (OMB#: 0938–0618);
Frequency: Quarterly and occasionally;
Affected Public: State, Local, or Tribal
Governments; Number of Respondents:
50; Total Annual Responses: 40; Total
Annual Hours: 3,200. (For policy
questions regarding this collection
AGENCY:
E:\FR\FM\21JAN1.SGM
21JAN1
]]>Agencies
[Federal Register Volume 76, Number 14 (Friday, January 21, 2011)]
[Notices]
[Page 3909]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-1232]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention (CDC)--Ethics Subcommittee (ES)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
subcommittee:
Times and Dates:
1 p.m.-5 p.m., February 17, 2011; 8:30 a.m.-12:30 p.m., February
18, 2011.
Place: CDC, Thomas R. Harkin Global Communications Center, Distance
Learning Auditorium, 1600 Clifton Road, NE., Atlanta, GA 30333. This
meeting is also available by teleconference. Please dial (877) 928-1204
and enter code 4305992.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 60 people. To accommodate
public participation in the meeting, a conference telephone line will
be available. The public is welcome to participate during the public
comment. The public comment periods are tentatively scheduled for 4
p.m.-4:15 p.m. on February 17, 2011 and from 12 p.m.-12:15 p.m. on
February 18, 2011.
Purpose: The ES will provide counsel to the ACD, CDC, regarding a
broad range of public health ethics questions and issues arising from
programs, scientists and practitioners.
Matter To Be Discussed: Agenda items will include the following: A
review of public comments submitted on the ethical considerations
document for the allocation of ventilators during a severe pandemic;
finalizing the presentation for the ACD on ethical issues related to
non-communicable disease prevention and control; and a review of the
outcome of discussions with state, tribal, local, and territorial
health officers on public health ethics challenges, including an
assessment of available options towards the development of practical
tools to assist health departments in their efforts to address these
challenges.
The agenda is subject to change as priorities dictate.
Contact Person for More Information: For security reasons, members
of the public interested in attending the meeting should contact Drue
Barrett, PhD, Designated Federal Officer, ACD, CDC-ES, 1600 Clifton
Road, NE., M/S D-50, Atlanta, Georgia 30333. Telephone (404) 639-4690.
E-mail: dbarrett@cdc.gov. The deadline for notification of attendance
is February 11, 2011.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: January 14, 2011.
Lorenzo J. Falgiano,
Acting Director, Management Analysis and Service Office, Centers for
Disease Control and Prevention.
[FR Doc. 2011-1232 Filed 1-20-11; 8:45 am]
BILLING CODE 4163-18-P
